ANDREA LIATIS: Open Payments
NPI 1588055891 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 31 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $446 · 2025 $776
Food & beverage: $684Education: $92
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $92 |
| Genentech USA, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| GENZYME CORPORATION | 1 | $35 |
| PharmaEssentia USA Corporation | 1 | $27 |
Products named: Enhertu, Venclexta, ELREXFIO, SARCLISA, DARZALEX, KISQALI, BESREMI, clonoSEQ.
Industry payments across GA — which companies pay providers there.
